Biotech company Biora Therapeutics, Inc. (BIOR) announced Tuesday that its BioJet Systemic Oral Delivery Platform has met key performance milestones as part of its research collaboration with British drug major AstraZeneca plc (AZN.L, AZN).
The BioJet platform is designed to use needle-free, liquid jet injection to deliver drug into the small intestine for systemic absorption.
The results met the company's performance targets of greater than 25% bioavailability compared to subcutaneous delivery, and less than 50% coefficient of variation.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.